88
10
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T37149 |
Carbamazepine 10,11-epoxide
|
Others | Others |
Carbamazepine 10,11-epoxide 是抗惊厥药卡马西平 (carbamazepine) 的活性代谢物。它由卡马西平通过微粒体中的细胞色素 P450 (CYP) 同种型 CYP3A4 和 CYP2C8 形成,微粒体分别由表达 CYP3A4 或 CYP2C8 的 HepG2 细胞制备。它对小鼠电击诱发的癫痫发作具有抗惊厥活性。 | |||
TQ0300 |
Conduritol B epoxide
|
Glucosidase | Metabolism |
Conduritol B epoxide 是不可逆的,β-glucosidase 共价抑制剂。 | |||
T19277 |
Dexamethasone 9,11-epoxide
|
Others | Others |
Dexamethasone 9,11-epoxide 是一种萃取得到的化合物,是制备地塞米松的中间体。 | |||
T35973 |
Cholesterol-5α,6α-epoxide
Epoxycholesterol,5α,6α-epoxy Cholestanol,NSC 18176 |
Others | Others |
Cholesterol-5α,6α-epoxide (Epoxycholesterol) 是胆固醇氧化产生的代谢产物。 在应用他莫昔芬和 PBPE 后,5α,6α-环氧胆甾烷醇通过与 LXRβ 结合诱导三酰甘油生物合成。 | |||
T36730 |
Vitamin K1 2,3-epoxide
Vitamin K1 epoxide,Phylloquinone oxide,Vitamin K1 2,3-epoxide |
Others | Others |
Vitamin K1 2,3-epoxide (Phylloquinone oxide) 可被还原为维生素 k,参与维生素k的循环。 | |||
T83857 |
Soluble Epoxide Hydrolase PROTAC 1a
sEH Proteolysis-targeting Chimera 1a,Soluble Epoxide Hydrolase Proteolysis-targeting Chimera 1a,sEH PROTAC 1a |
||
Soluble epoxide hydrolase (sEH) PROTAC 1a是一种利用蛋白质降解靶向嵌合体(PROTAC)技术,通过连接区域将cereblon配体1与sEH抑制剂t-TUCB结合。该化合物通过促进sEH的降解,特异性抑制sEH的水解酶活性(IC50 = 0.8 nM),相较于其磷酸酶活性(IC50 = >10,000 nM)具有较高选择性。sEH PROTAC 1a还特定促进细胞质中而非过氧体中的sEH降解,并通过溶酶体而非蛋白酶体实现其降解。它能够降低thapsigargin诱导的HepG2与293T细胞中磷酸化的inositol-requiring enzyme 1α (IRE1α)水平和X-box结合蛋白1 (XBP1)剪接,表明能减少ER应激。 | |||
T12974 |
Soluble epoxide hydrolase inhibitor
|
Others | Others |
Soluble epoxide hydrolase inhibitor is a soluble epoxide hydrolase inhibitor (human soluble epoxide hydrolase (h-sEH) with pIC50 of 8.4). | |||
T29690 |
Aflatoxin G1 9,10-epoxide
|
||
Aflatoxin G1 9,10-epoxide is a biochemical. | |||
T32059 |
Hepaxanthin
Vitamin A epoxide |
||
Hepaxanthin is a carotenoid. | |||
T7898 |
AUDA
|
Epoxide Hydrolase | Metabolism |
AUDA 是可溶性环氧化物水解酶 (sEH) 抑制剂,在小鼠和人 sEH 的IC50分别为 18 和 69 nM,具有抗炎特性。 | |||
T34627 |
SFO
Safrole epoxide,Safrole oxide |
||
SFO is an endothelial-to-mesenchymal transition (EndoMT) inducer. | |||
T7199 |
TPPU
|
Epoxide Hydrolase | Metabolism |
TPPU 是一种可溶性环氧化物水解酶(sEH)抑制剂,对猴子和人类的IC50分别为37和3.7 nM。 | |||
T14557 |
BI-1935
|
Epoxide Hydrolase | Metabolism |
BI-1935 是可溶性环氧化物水解酶抑制剂,用于与心血管疾病相关的疾病的研究。 | |||
T17158 |
trans-AUCB
t-AUCB |
Epoxide Hydrolase | Metabolism |
trans-AUCB (t-AUCB) 是口服具有活力的、选择性的可溶性环氧水解酶 (sEH) 抑制剂,对人,小鼠和大鼠的 sEH 的IC50分别为 1.3 nM,8 nM,8 nM。它具有抗神经胶质瘤特性。 | |||
T34070 |
Piperitenone oxide
Rotundifolone,Lippione,cis-Piperitenone epoxide,Piperitenone oxide, (+-)- |
||
Piperitenone oxide is a major chemical constituent of the carvone pathway MS essential oil. | |||
T14315 |
AR-9281
APAU |
Epoxide Hydrolase | Metabolism |
AR-9281 (APAU) 是选择性的可溶性环氧化物水解酶抑制剂,可用于研究高血压和 2 型糖尿病。 | |||
T10900 |
CUDA
|
PPAR; Epoxide Hydrolase | DNA Damage/DNA Repair; Metabolism |
CUDA 是一种可溶性环氧水解酶抑制剂,对小鼠 sEH 和人 sEH 作用的 IC50分别为 11.1 和 112 nM。它能选择性地上调过氧化物酶体增殖激活受体 PPARα的活性,有用于心血管疾病的研究潜力。 | |||
T11147 |
EC5026
BPN-19186 |
Epoxide Hydrolase | Metabolism |
EC5026 (BPN-19186) 是首创的,非阿片类的,可溶性环氧水解酶 (sEH) 抑制剂,它可有效缓解发炎性和神经性疼痛。 | |||
T8844 |
Diflapolin
|
Others; FLAP; Epoxide Hydrolase | Immunology/Inflammation; Metabolism; Others |
Diflapolin 是高活性的双 5-脂氧合酶激活蛋白(FLAP)/可溶性环氧化物水解酶抑制剂,具有显著的抗炎作用和较高的靶向选择性。它抑制分离的 sEH 的活性,IC50为20 nM。它还抑制完整人单核细胞和中性粒细胞中 5-LOX 产物的形成,IC50分别为 30 和 170 nM。 | |||
T17196 |
UC-1728
t-TUCB |
Epoxide Hydrolase | Metabolism |
UC-1728 (t-TUCB) 是一种兔子可溶性环氧化物水解酶抑制剂,兔子肝脏中测得其IC50=2 nM。 | |||
T130051 |
Detigloylswietenine, 2-Hydroxy, 8?,30?-epoxide, 3-
|
||
Detigloylswietenine, 2-Hydroxy, 8?,30?-epoxide, 3- 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T130051。 | |||
T21859 |
ARM1
|
Aminopeptidase; Epoxide Hydrolase | Metabolism |
ARM1 是氨基肽酶和环氧化物水解酶抑制剂,IC50分别为为7.61 µM 和12.4 µM。 | |||
T15430 |
GSK2256294A
GSK 2256294 |
Others; Epoxide Hydrolase | Metabolism; Others |
GSK2256294A (GSK 2256294) 是重组人、大鼠和小鼠 sEH 的有效特异性抑制剂,IC50 分别为 27 pM、61 pM 和 189 pM。 | |||
T0355 |
Valpromide
Depamide,Valpramide,丙戊酰胺,Dipropylacetamide,2-propylpentanamide |
Epoxide Hydrolase; HSV | Metabolism; Microbiology/Virology |
Valpromide (Dipropylacetamide) 是丙戊酸的羧酰胺衍生物,用于治疗癫痫和一些情感障碍。 | |||
T8315 |
1-Cyclohexyl-3-dodecyl urea
CDU,N-Cyclohexyl-N-dodecyl urea,NCND |
Epoxide Hydrolase | Metabolism |
1-Cyclohexyl-3-dodecyl urea (NCND) 是高选择性的可溶性环氧化物水解酶 (sEH) 抑制剂,能够增强血管紧张素 II (Ang II) 高血压中的环氧二十碳三烯酸 (EETs) 水平,并降低血压。 | |||
T23044 |
N,N'-Dicyclohexylurea
DCU,1,3-Dicyclohexylurea,NSC 17013,Dicyclohexylurea,Dicyclohexylcarbodiamide,AURORA KA-3582,N,N-二环己脲 |
Epoxide Hydrolase | Metabolism |
N,N'-Dicyclohexylurea (AURORA KA-3582) 是一种可溶性环氧化物水解酶 (sEH) 抑制剂。 | |||
T131605 | Crotepoxide (Futoxide) | ||
Crotepoxide (Futoxide) 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T131605。 | |||
T2716 |
1,3-Diphenylurea
|
Epoxide Hydrolase | Metabolism |
1,3-Diphenylurea 与环氧化物水解酶活性有关。 | |||
T63536 |
Dual FAAH/sEH-IN-1
|
FAAH; Epoxide Hydrolase | Metabolism; Neuroscience |
Dual FAAH/sEH-IN-1 是具有高度亲和力的sEH(可溶性环氧水解酶) (IC50: 9.6 nM) 和FAAH(脂肪酸酰胺水解酶) (IC50: 7 nM) 双重抑制剂,具有抗炎活性。 | |||
T17025 |
Tecarfarin
ATI-5000,ATI-5923 |
Others | Others |
Tecarfarin (ATI-5923) 是一种具有口服活性和有效性的维生素 K 环氧化物还原酶 (VKOR) 拮抗剂和大麻素-1受体反向激动剂,具有抗血栓形成活性,可减轻小鼠的腹痛并增加肠道转运。 | |||
T38367 |
CAY10640
sEH inhibitor-1 |
Epoxide Hydrolase | Metabolism |
CAY10640 (sEH inhibitor-1)一种有效的、具有口服活性、可溶于水的环氧化物水解酶 (sEH) 抑制剂,对人和鼠中的sEH 具有抑制作用,IC50s 分别为 0.4 和 5.3 nM。 | |||
T60358 |
sEH inhibitor-7
|
Epoxide Hydrolase | Metabolism |
sEH inhibitor-7是一种可溶性环氧化物水解酶(sEH)抑制剂,对人和小鼠的 sEH 有抑制作用,IC 50 s 分别为 6.2 μM 和0.15 μM 。sEH inhibitor-7与抗炎活性分子有关。 | |||
T9832 |
(Rac)-EC5026
Urea, N-[3-fluoro-4-(trifluoromethoxy)phenyl]-N'-[1-(2-methyl-1-oxobutyl)-4-piperidinyl]- |
Epoxide Hydrolase | Metabolism |
(Rac)-EC5026 ((Rac)-BPN-19186) 是一种有效的可溶性环氧水解酶 (sEH) 哌啶抑制剂,Ki 值为 0.06 nM。(Rac)-EC5026 可用于帕金森氏病和路易体痴呆 (DLB) 的研究。 | |||
T36696 |
DMBA
|
||
7,12-Dimethylbenz[a]anthracene (DMBA) is a polycyclic aromatic hydrocarbon (PAH) that has been found in tobacco smoke and diesel exhaust and has carcinogenic activity.1,2It undergoes metabolic activation by numerous enzymes, including the cytochrome P450 (CYP450) isoform CYP1B1, as well as microsomal epoxide hydrolase (mEH), producing a variety of reactive metabolites that form DNA adductsin vivo, and it has been commonly used to induce tumor formation in various rodent models.2,3,1DMBA increase... | |||
T68786 |
Orniplabin
|
||
Orniplabin, also known as SMTP-7 is a dual inhibitor of thrombolysis and soluble epoxide hydrolase. SMTP-7 promotes thrombolysis and inhibits soluble epoxide hydrolase. | |||
T24778 |
sEH-IN-12
sEH inhibitor 12,sEH-inhibitor-12 |
||
sEH-IN-12 is an effective inhibitor of the enzyme soluble epoxide hydrolase (sEH). | |||
T32310 | Johnstonol | ||
Johnstonol is an specifically halogenated epoxide obtained from the red alga. | |||
T37239 |
(±)19(20)-EpDTE
|
||
(±)19(20)-EpDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid . It is formed via cytochrome P450 (CYP) metabolism of DPA and can be further metabolized to (±)19(20)-DiHDTE by epoxide hydrolase. | |||
T32385 | Keto-anhydrokinamycin | ||
Keto-anhydrokinamycin, as a keto-epoxide kinamycin intermediate, is isolated from Streptomyces murayamaensis. | |||
T37334 |
(±)11,12-DiHETE
|
||
(±)11,12-DiHETE is a dihydroxy metabolite of EPA produced by cytochrome P450-mediated epoxide formation and subsequent hydrolysis by epoxide hydrolase. Plasma levels of (±)11,12-DiHETE are increased over baseline after an oral dose of 1008 mg EPA. | |||
T68259 |
TUPS
|
||
TUPS is a selective soluble epoxide hydrolase inhibitor which protects against isoprenaline-induced cardiac hypertrophy. | |||
T17024 |
Tecarfarin sodium
ATI-5923 sodium |
Others | Others |
Tecarfarin sodium is a novel orally active non-competitive vitamin K epoxide reductase antagonist. Tecarfarin sodium has the antithrombotic activity. | |||
T37226 |
(±)7(8)-EpDTE
|
||
(±)7(8)-EpDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid . It is formed via cytochrome P450 (CYP) metabolism of DPA, and can be further metabolized to (±)7(8)-DiHDTE by epoxide hydrolase. | |||
T13042 |
SWE101
|
Others | Others |
SWE101 is a potent human and rat soluble epoxide hydrolase (sEH)-P inhibitor(IC50s of 4 μM and 2.8 μM, respectively). | |||
T70626 |
MS 347a
|
||
MS 347a is a myosin light chain kinase (MLCK) inhibitor; an epoxide analog of sydowinin B (MS-347b). | |||
T35496 |
(±)13(14)-EpDPA
|
||
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)13(14)-EpDPA is a docosahexaenoic acid epoxygenase metabolite, derived via epoxidation of the 13,14-double bond of DHA. It has been detected in rat brain and spinal cord and is a preferred substrate for soluble epoxide hydrolase with a Km value of 3.2 μM. (±)13(14)-EpDPA demonstrates antihyperalgesic activity in inflammatory and neuropathic pain models. (±)13(14)-EpDPA and other epoxy m... | |||
T61541 |
sEH inhibitor-6
|
||
sEH inhibitor-6 (Compound 3g) is a highly potent soluble epoxide hydrolase (sEH) inhibitor, exhibiting an IC 50 value of 0.5 nM [1]. | |||
T64291 | sEH inhibitor-1 | ||
sEH inhibitor-1 (compound TCPU ) 是一种有效的、口服具有活力的可溶性环氧化物水解酶 (sEH) 抑制剂,对人和鼠 she 的 IC50 值分别为 0.4 和 5.3 nM。 | |||
T35493 |
(±)10(11)-EpDPA
|
||
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. (±)10(11)-EpDPA is a docosahexaenoic acid epoxygenase metabolite, derived via epoxidation of the 10,11-double bond of DHA. It has been detected in rat brain and spinal cord, as well as human serum, and acts as a substrate for soluble epoxide hydrolase with a Km value of 5.1 μM. (±)10(11)-EpDPA and other epoxy metabolites of DHA are reported to demonstrate antihyperalgesic activity in infla... | |||
T37652 |
5(S),6(R)-DiHETE
|
||
5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in guinea pig lung membranes. It induces guinea pig ileum contraction with an ED50 value of 1.3 μM. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN4130 | Germacrone 4,5-epoxide | gp120/CD4; IL Receptor; P450 | Immunology/Inflammation; Metabolism |
(4S,5S)-(+)-Germacrone-4,5-epoxide inhibits certain subtypes of cytochrome P450 (CYP). | |||
TN4229 | Humulene epoxide II | Antifection | Microbiology/Virology |
Humulene epoxide II has antimalarial activity. | |||
TN4958 |
Schisandrin C epoxide
|
Others | Others |
Schisandrin C epoxide 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN4958,CAS号为 81345-36-0。 | |||
TN6794 |
N-(3-methoxybenzyl)-octadecanamide
|
Others | Others |
N-(3-methoxybenzyl)-octadecanamide 从玛卡 (Lepidium meyenii Walp.) 转化而来。 | |||
TN1078 |
Seneciphylline
千里光菲灵碱,千里光非灵 |
P450; GST | Metabolism; oxidation-reduction |
Seneciphylline 是一种有毒的吡咯烷核生物碱,存在于千里光植物中。它显著增加了环氧水合酶和谷胱甘肽-S-转移酶的特性,但导致细胞色素 P-450 和相关单加氧酶特性的抑制。 | |||
TN5329 | Epitulipinolide diepoxide | ||
Epitulipinolide diepoxide has antioxidative and chemopreventive activities in skin melanoma cells, can significantly inhibit the proliferation of melanoma cells, it possesses cytotoxic activity against KB cells. | |||
T73797 |
Cladospirone bisepoxide
|
||
Cladospirone bisepoxide 是一种从真菌培养物中分离出来的代谢物。Cladospirone bisepoxide 对几种细菌和真菌表现出选择性抗生素活性,并在低浓度下抑制Lepidium sativum 萌发。 | |||
T15039 |
Cytochalasin E
|
Others | Others |
Cytochalasin E is a potent actin depolymerization agent and an epoxide containing Aspergillus-derived fungal metabolite. Cytochalasin E also inhibits angiogenesis and tumor growth. It binds and caps the barbed end of actin filaments to prevent actin elong | |||
T37272 |
9(S),12(S),13(S)-TriHOME
|
||
9(S),12(S),13(S)-TriHOME is a linoleic acid-derived oxylipin that has diverse biological activities.1,2,3,4It has been found in various plants and is produced in human eosinophils in a 15-lipoxygenase-dependent, soluble epoxide hydrolase-independent manner.1,59(S),12(S)13(S)-TriHOME inhibits antigen-induced β-hexosaminidase release from RBL-2H3 mast cells (IC50= 28.7 μg/ml).2It inhibits LPS-induced nitric oxide (NO) production in BV-2 microglia (IC50= 40.95 μM).3In vivo, 9(S),12(S),13(S)-TriHOME... | |||
TN4592 |
Murrangatin
|
IL Receptor; TNF; COX; Prostaglandin Receptor | Apoptosis; GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Murrangatin may be a valuable anti-tumor-promoting agent, it can significantly inhibit Epstein-Barr virus early antigen (EBV-EA) activation, and preserve the high viability of Raji cells, it also exhibits cytotoxicity against cholangiocarcinoma cell line, |